Clinical Trial Update: A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial comparing ABT-335 plus rosuvastatin calcium to rosuvastatin monotherapy in dyslipidemia/hypercholesterolemia. The study is completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• ABT-335
• ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-01